Spots Global Cancer Trial Database for high performance liquid chromatography
Every month we try and update this database with for high performance liquid chromatography cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the Prostate | NCT00459407 | Adenocarcinoma ... Stage I Prostat... Stage II Prosta... | defined green t... placebo immunohistochem... immunoenzyme te... laboratory biom... biopsy mass spectromet... high performanc... | 18 Years - | National Cancer Institute (NCI) | |
Positron Emission Tomography Using [18F]-Labeled Substance P Antagonist Receptor Quantifier in Finding Disease in Patients With Pancreatic Cancer | NCT00547612 | Pancreatic Canc... | high performanc... pharmacological... [18F]-labeled s... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | NCT00770471 | Brain and Centr... | temozolomide veliparib DNA methylation... gene expression... mutation analys... proteomic profi... high performanc... immunoenzyme te... laboratory biom... mass spectromet... pharmacogenomic... pharmacological... adjuvant therap... radiation thera... | 18 Years - 120 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer | NCT00516698 | Breast Cancer | polymorphism an... high performanc... laboratory biom... radiomammograph... | 18 Years - | Alliance for Clinical Trials in Oncology | |
Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection | NCT00513461 | Adult Primary L... Hepatitis C Inf... | S-adenosyl-L-me... placebo laboratory biom... immunoenzyme te... high performanc... | 18 Years - | University of California, Irvine | |
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer | NCT00516698 | Breast Cancer | polymorphism an... high performanc... laboratory biom... radiomammograph... | 18 Years - | Alliance for Clinical Trials in Oncology | |
Biomarker 11-dh-TXB2 in Blood and Urine Samples From Patients With Prostate Cancer and Healthy Volunteers | NCT00984919 | Prostate Cancer | high performanc... laboratory biom... mass spectromet... | 40 Years - 120 Years | Barbara Ann Karmanos Cancer Institute | |
Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin Lymphoma | NCT00691652 | Lymphoma | rituximab clofarabine DNA methylation... gene expression... microarray anal... polymerase chai... high performanc... laboratory biom... | 18 Years - 89 Years | OHSU Knight Cancer Institute | |
BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors | NCT00526149 | Breast Cancer Endometrial Can... Head and Neck C... Melanoma (Skin) Ovarian Cancer Sarcoma | BI 2536 high performanc... mass spectromet... pharmacological... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
Pralatrexate and Fluorouracil in Treating Patients With Recurrent Solid Tumors | NCT01206465 | Unspecified Adu... | pralatrexate fluorouracil laboratory biom... DNA analysis high performanc... polymerase chai... nucleic acid se... pharmacological... pharmacogenomic... polymorphism an... | 19 Years - | University of Nebraska | |
White Button Mushroom Extract in Preventing the Recurrence of Breast Cancer in Postmenopausal Breast Cancer Survivors | NCT00709020 | Breast Cancer Cancer Survivor | white button mu... flow cytometry high performanc... laboratory biom... mass spectromet... pharmacogenomic... pharmacological... | 21 Years - | City of Hope Medical Center | |
Nutrition-Related Biomarkers in Predicting Breast Cancer Risk in Women | NCT00900367 | Breast Cancer | high performanc... laboratory biom... spectroscopy | - 120 Years | Brigham and Women's Hospital | |
Hydroxychloroquine and Temozolomide in Treating Patients With Metastatic or Unresectable Solid Tumors | NCT00714181 | Unspecified Adu... | hydroxychloroqu... temozolomide TdT-mediated dU... western blottin... electron micros... high performanc... immunoenzyme te... immunohistochem... laboratory biom... mass spectromet... pharmacological... | 18 Years - 120 Years | Abramson Cancer Center at Penn Medicine | |
Dexrazoxane and Cisplatin in Treating Patients With Advanced Solid Tumors | NCT00550901 | Unspecified Adu... | cisplatin dexrazoxane hyd... high performanc... laboratory biom... mass spectromet... pharmacological... | 18 Years - | City of Hope Medical Center | |
Biomarker 11-dh-TXB2 in Blood and Urine Samples From Patients With Prostate Cancer and Healthy Volunteers | NCT00984919 | Prostate Cancer | high performanc... laboratory biom... mass spectromet... | 40 Years - 120 Years | Barbara Ann Karmanos Cancer Institute | |
Effect of Tamoxifen or an Aromatase Inhibitor on Estrogen Metabolism in Women Treated for Newly Diagnosed Breast Cancer | NCT00569543 | Breast Cancer | high performanc... laboratory biom... mass spectromet... medical chart r... | 19 Years - | University of Nebraska | |
A Phase I Trial of Normothermic Isolated Limb Infusion (ILI) With Melphalan Plus Buthionine Sulfoximine (BSO) in Patients With Locally Advanced Malignant Melanoma | NCT00661336 | Melanoma (Skin) | buthionine sulf... melphalan microarray anal... high performanc... laboratory biom... pharmacological... biopsy | 18 Years - | Duke University | |
Hydroxychloroquine and Temozolomide in Treating Patients With Metastatic or Unresectable Solid Tumors | NCT00714181 | Unspecified Adu... | hydroxychloroqu... temozolomide TdT-mediated dU... western blottin... electron micros... high performanc... immunoenzyme te... immunohistochem... laboratory biom... mass spectromet... pharmacological... | 18 Years - 120 Years | Abramson Cancer Center at Penn Medicine | |
Dietary Phytoestrogens, Complementary and Alternative Medicine, and Lifestyle in Predicting Survival of Women With Breast Cancer | NCT00691509 | Breast Cancer | gene expression... polymorphism an... high performanc... laboratory biom... mass spectromet... questionnaire a... | - 75 Years | National Cancer Institute (NCI) | |
Studying Genes to Identify Melanoma in Patients in Iceland and Their Family Members | NCT00346008 | Melanoma (Skin) | mutation analys... high performanc... laboratory biom... questionnaire a... | - | National Cancer Institute (NCI) | |
N2004-03: Intravenous Fenretinide in Treating Young Patients With Recurrent or Resistant Neuroblastoma | NCT00646230 | Neuroblastoma | fenretinide high performanc... pharmacological... | 0 Years - 30 Years | Children's Hospital Los Angeles | |
Pharmacogenetics of Anastrozole in Postmenopausal Women With Estrogen Receptor-Positive and/or Progesterone Receptor-Positive Stage I, Stage II, or Stage III Breast Cancer | NCT00283608 | Breast Cancer | Single nucleoti... high performanc... measurements by... questionnaire a... | 18 Years - | Mayo Clinic | |
Entinostat And Imatinib Mesylate In Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia | NCT01383447 | Philadelphia Ch... Recurrent Adult... | entinostat imatinib mesyla... laboratory biom... pharmacological... western blottin... immunohistochem... flow cytometry polymerase chai... high performanc... mass spectromet... | 18 Years - | National Cancer Institute (NCI) | |
BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors | NCT00526149 | Breast Cancer Endometrial Can... Head and Neck C... Melanoma (Skin) Ovarian Cancer Sarcoma | BI 2536 high performanc... mass spectromet... pharmacological... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
Breath Test for Women Receiving Tamoxifen in the Prevention or Treatment of Breast Cancer | NCT00873366 | Breast Cancer | dextromethorpha... tamoxifen citra... high performanc... laboratory biom... pharmacogenomic... pharmacological... fluorescence im... | 18 Years - 120 Years | Mayo Clinic | |
Yttrium Y 90 DOTA Anti-CEA Monoclonal Antibody M5A in Treating Patients With Advanced Solid Tumors | NCT00645060 | Unspecified Adu... | high performanc... pharmacological... radionuclide im... single photon e... yttrium Y 90 DO... | 18 Years - 120 Years | City of Hope Medical Center | |
Studying Genes to Identify Melanoma in Patients in Iceland and Their Family Members | NCT00346008 | Melanoma (Skin) | mutation analys... high performanc... laboratory biom... questionnaire a... | - | National Cancer Institute (NCI) | |
Defined Green Tea Catechin Extract in Treating Patients With Localized Prostate Cancer Undergoing Surgery | NCT01340599 | Stage I Prostat... Stage IIA Prost... Stage IIB Prost... | defined green t... placebo immunohistochem... immunoenzyme te... questionnaire a... therapeutic con... high performanc... mass spectromet... | 45 Years - 75 Years | Case Comprehensive Cancer Center | |
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Stage I-IIIB Non-Small Cell Lung Cancer After Completion of Radiation Therapy Alone or Combined Radiation Therapy and Chemotherapy | NCT00738452 | Lung Cancer | high performanc... pharmacological... radionuclide im... single photon e... radiation thera... yttrium Y 90 an... | 18 Years - | City of Hope Medical Center | |
Study of Urine Samples From Women With Newly Diagnosed Breast Cancer Enrolled on Clinical Trial UNMC-08105 | NCT00959244 | Breast Cancer | high performanc... laboratory biom... mass spectromet... medical chart r... | 19 Years - | University of Nebraska | |
Curcumin in Preventing Colorectal Cancer in Patients Undergoing Colorectal Endoscopy or Colorectal Surgery | NCT00973869 | Colorectal Canc... | curcumin high performanc... laboratory biom... pharmacological... diagnostic endo... therapeutic con... | 18 Years - | National Cancer Institute (NCI) | |
Effect of Tamoxifen or an Aromatase Inhibitor on Estrogen Metabolism in Women Treated for Newly Diagnosed Breast Cancer | NCT00569543 | Breast Cancer | high performanc... laboratory biom... mass spectromet... medical chart r... | 19 Years - | University of Nebraska | |
Vinorelbine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Treatment and Liver Dysfunction | NCT00540982 | Lung Cancer Unspecified Adu... | indocyanine gre... lidocaine vinorelbine dit... high performanc... intracellular f... liquid chromato... mass spectromet... pharmacological... | 18 Years - 120 Years | City of Hope Medical Center | |
Hydroxychloroquine and Temsirolimus in Treating Patients With Metastatic Solid Tumors That Have Not Responded to Treatment | NCT00909831 | Unspecified Adu... | hydroxychloroqu... temsirolimus electron micros... high performanc... immunologic tec... laboratory biom... mass spectromet... pharmacological... autophagy inhib... | 18 Years - 120 Years | Abramson Cancer Center at Penn Medicine | |
Study of Urine Samples From Women With Newly Diagnosed Breast Cancer Enrolled on Clinical Trial UNMC-08105 | NCT00959244 | Breast Cancer | high performanc... laboratory biom... mass spectromet... medical chart r... | 19 Years - | University of Nebraska | |
A Phase I Trial of Normothermic Isolated Limb Infusion (ILI) With Melphalan Plus Buthionine Sulfoximine (BSO) in Patients With Locally Advanced Malignant Melanoma | NCT00661336 | Melanoma (Skin) | buthionine sulf... melphalan microarray anal... high performanc... laboratory biom... pharmacological... biopsy | 18 Years - | Duke University | |
N2004-03: Intravenous Fenretinide in Treating Young Patients With Recurrent or Resistant Neuroblastoma | NCT00646230 | Neuroblastoma | fenretinide high performanc... pharmacological... | 0 Years - 30 Years | Children's Hospital Los Angeles |